EXHIBIT 10.1
 

 
ANTRIABIO, INC.
(a Delaware corporation)

1450 Infinite Drive
Louisville, Colorado 80027

--------------------------------------------------------------------------------

COMMON STOCK PURCHASE AGREEMENT

--------------------------------------------------------------------------------

Instructions

PLEASE COMPLETE ONE COPY OF THE COMMON STOCK PURCHASE
AGREEMENT

THE SECURITIES TO WHICH THIS COMMON STOCK PURCHASE AGREEMENT (THE “PURCHASE
AGREEMENT”) RELATES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE AND WILL BE ISSUED IN
RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933,
AS AMENDED (THE “U.S. SECURITIES ACT”) AND UNDER APPLICABLE STATE SECURITIES
LEGISLATION, AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE U.S. SECURITIES ACT OR PURSUANT TO AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE U.S. SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
AND PROVINCIAL SECURITIES LAWS.

January 18, 2017
 
1

--------------------------------------------------------------------------------

ANTRIABIO, INC.
COMMON STOCK PURCHASE AGREEMENT
The undersigned (the “Purchaser”) hereby irrevocably agrees to purchase from
AntriaBio, Inc. (the “Company”) that number of shares of common stock (“Common
Stock”), set out below at a price of $1.00 per Common Stock.  The Purchaser
agrees to be bound by the terms and conditions set forth in the attached “Terms
and Conditions of Purchase for Common Stock” including without limitation the
representations, warranties and covenants set forth in the applicable schedules
attached thereto. The Purchaser further agrees, without limitation, that each of
the Company and Samsung Securities Co., Ltd (the “Placement Agent”) may rely
upon the Purchaser’s representations, warranties and covenants contained in such
documents.

Please complete and sign the Selling Shareholder Questionnaire – Exhibit A.
 
 
2

--------------------------------------------------------------------------------

SUBSCRIPTION AND PURCHASER INFORMATION
Please print all information (other than signatures), as applicable, in the
space provided below
 
 
_________________________________________________
 
 
Number of Common Stock:                                                       x
$1.00
(Ne of Purchaser)
       
=
Account Reference (if applicable): _______________________ 
   
 
By: ______________________________________________
 
Aggregate Purchase Price: _____________________________ 
(the “Purchase Price”)
Authorized Signature
         
_________________________________________________ 
(Official Capacity or Title – if the Purchaser is not an individual)
 
_________________________________________________ 
(Name of individual whose signature appears above if different than the name of
the Purchaser printed above.)
 
_________________________________________________ 
(Purchaser’s Address, including Municipality and Province)

_________________________________________________ 
S.I.N. or Taxation Account of Purchaser
  _________________________________________________
(Telephone Number)                                                  (Email
Address)
 
 
If the Purchaser is signing as agent for a principal (beneficial purchaser) and
is not purchasing as trustee or agent for accounts fully managed by it, complete
the following:
 
__________________________________________________ 
(Name of Principal)
 
__________________________________________________ 
(Principal’s Address)

__________________________________________________  
 
     
 
Account Registration Information:
 
_________________________________________________ 
(Name)
 
_________________________________________________ 
(Account Reference, if applicable)
 
_________________________________________________ 
(Address, including Postal Code)
 
 
Delivery Instructions as set forth below:
 
__________________________________________________ 
(Name)
 
__________________________________________________ 
(Account Reference, if applicable)
 
__________________________________________________ 
(Address)
 
__________________________________________________ 
(Contact Name)                                                    (Telephone
Number)

 
3

--------------------------------------------------------------------------------

COMMON STOCK PURCHASE AGREEMENT
ANTRIABIO, INC.
(a Delaware corporation)

1.   Common Stock Purchase: The undersigned (“Purchaser”) irrevocably subscribes
for and agrees to purchase from AntriaBio, Inc., a Delaware corporation
(“Antria” or the “Company”), that number of Common Stock (“Common Stock”) set
out in the “SUBSCRIPTION AND PURCHASER INFORMATION” at a price of $1.00 per
share of Common Stock (the “Purchase Price”).  The Common Stock issuable
hereunder may be hereinafter referred to as the “Offered Securities” or
“Securities”.  All figures are in United States Dollars unless otherwise
specified and the acquisition of the Securities is subject to the following
terms and conditions:

a. Tender of Purchase Price:  Purchaser tenders to Antria the Purchase Price
pursuant to the instructions set forth on Schedule I.

b. Closing:  Upon receipt by Antria of the Purchase Price and satisfaction of
the Conditions set forth herein (the “Conditions”), the Company may conduct a
series of closings relating to the Offering (each a “Closing”) with the final
Closing of the Offering to occur on such time as determined by the Company in
its sole discretion (the “Closing Date”).  All funds will be delivered to
Antria.  The Securities subscribed for herein, will not be deemed issued to, or
owned by, the Purchaser until the Purchase Agreement has been executed by the
Purchaser and accepted by Antria, and all payments required to be made herein
have been made.  The Closing is subject to the fulfillment of the Conditions,
which Conditions Antria and the Purchaser covenant to exercise their reasonable
best efforts to have fulfilled on or prior to the Closing Date:

(i)
the Purchaser shall have tendered the Purchase Price to Antria;

(ii)
all relevant documentation and approvals as may be required by applicable
securities statutes, regulations, policy statements and interpretation notes, by
applicable securities regulatory authorities and by applicable rules shall have
been obtained and, where applicable, executed by or on behalf of the Purchaser;

(iii)
Antria shall have authorized and approved the execution and delivery of this
Purchase Agreement (“Agreement”) and the issuance, allotment and delivery of the
Securities; and

(iv)
the representations and warranties of Purchaser set forth in this Agreement
shall be true and correct as of the Closing Date.

c. Issuance of Securities:  Within three (3) days after the Closing, Antria will
deliver the certificates representing the Common Shares subscribed for to the
Purchaser at the address set forth in the registration instructions set forth on
the signature page (unless Purchaser otherwise instructs Antria in writing). 
None of the Common Stock issued in this Offering have been registered under the
Securities Act of 1933, as amended (“U.S. Securities Act”), or the securities
laws of any state in the United States.
 
4

--------------------------------------------------------------------------------

2.   Representations and Warranties of Purchaser: Purchaser hereby represents
and warrants to Antria:
(a) General:

(i)
Purchaser has all requisite authority (and in the case of an individual, the
capacity) to purchase the Offered Securities, enter into this Purchase Agreement
and to perform all the obligations required to be performed by Purchaser
hereunder, and such purchase will not contravene any law, rule or regulation
binding on Purchaser or any investment guideline or restriction applicable to
Purchaser.

(ii)
Purchaser will comply with all applicable laws and regulations in effect in any
jurisdiction in which Purchaser purchases or sells Offered Securities and obtain
any consent, approval or permission required for such purchases or sales under
the laws and regulations of any jurisdiction to which Purchaser is subject or in
which Purchaser makes such purchases or sales, and the Company shall have no
responsibility therefor.

(b) Information Concerning the Company:

(i)
Purchaser has received a copy of the private placement memorandum (the
“Memorandum”). Purchaser has not been furnished any offering literature other
than the Memorandum and has relied only on the information contained therein.

(ii)
Purchaser understands and accepts that the purchase of the Offered Securities
involves various risks, including the risks outlined in the Memorandum and in
this Purchase Agreement. Purchaser represents that it is able to bear any loss
associated with an investment in the Offered Securities.

(iii)
Purchaser confirms that it is not relying on any communication (written or oral)
of the Company or any of its affiliates, as investment advice or as a
recommendation to purchase the Offered Securities. It is understood that
information and explanations related to the terms and conditions of the Offered
Securities provided in the Memorandum or otherwise by the Company or any of its
affiliates shall not be considered investment advice or a recommendation to
purchase the Offered Securities, and that neither the Company nor any of its
affiliates is acting or has acted as an advisor to Purchaser in deciding to
invest in the Offered Securities. Purchaser acknowledges that neither the
Company nor any of its affiliates has made any representation regarding the
proper characterization of the Offered Securities for purposes of determining
Purchaser's authority to invest in the Offered Securities.

(iv)
Purchaser is familiar with the business and financial condition and operations
of the Company, all as generally described in the Memorandum. Purchaser has had
access to such information concerning the Company and the Offered Securities as
it deems necessary to enable it to make an informed investment decision
concerning the purchase of the Offered Securities.

(v)
Purchaser understands that, unless Purchaser notifies the Company in writing to
the contrary at or before a Closing, each of Purchaser's representations and
 

5

--------------------------------------------------------------------------------

warranties contained in this Purchase Agreement will be deemed to have been
reaffirmed and confirmed as of a Closing, taking into account all information
received by Purchaser.

(vi)
Purchaser acknowledges that the Company has the right in its sole and absolute
discretion to abandon this Offering at any time prior to the completion of this
Offering. This Purchase Agreement shall thereafter have no force or effect and
the Company shall return the previously paid the Purchase Price of the Offered
Securities, without interest thereon, to Purchaser.

(vii)
Purchaser understands that no federal or state agency has passed upon the merits
or risks of an investment in the Offered Securities or made any finding or
determination concerning the fairness or advisability of this investment.

(c) Non-reliance:

(i)
Purchaser confirms that the Company has not (A) given any guarantee or
representation as to the potential success, return, effect or benefit (either
legal, regulatory, tax, financial, accounting or otherwise) of an investment in
the Offered Securities or (B) made any representation to Purchaser regarding the
legality of an investment in the Offered Securities under applicable legal
investment or similar laws or regulations. In deciding to purchase the Offered
Securities, Purchaser is not relying on the advice or recommendations of the
Company and Purchaser has made its own independent decision that the investment
in the Offered Securities is suitable and appropriate for Purchaser.

(d) Status of Undersigned:

(i)
Purchaser has such knowledge, skill and experience in business, financial and
investment matters that Purchaser is capable of evaluating the merits and risks
of an investment in the Offered Securities. With the assistance of Purchaser's
own professional advisors, to the extent that Purchaser has deemed appropriate,
Purchaser has made its own legal, tax, accounting and financial evaluation of
the merits and risks of an investment in the Offered Securities and the
consequences of this Purchase Agreement. Purchaser has considered the
suitability of the Offered Securities as an investment in light of its own
circumstances and financial condition and Purchaser is able to bear the risks
associated with an investment in the Offered Securities and its authority to
invest in the Offered Securities.

(ii)
Purchaser is an “accredited investor” as defined in Rule 501(a) under the U.S.
Securities Act. Purchaser agrees to furnish any additional information requested
by the Company or any of its affiliates to assure compliance with applicable
U.S. federal and state securities laws in connection with the purchase and sale
of the Offered Securities.

(e)
Restrictions on Transfer or Sale of Offered Securities: As applies to Purchaser:

(i)
Purchaser is acquiring the Offered Securities solely for Purchaser’s own
beneficial account, for investment purposes, and not with a view to, or for
resale in connection with, any distribution of the Offered Securities. Purchaser
understands that the Offered Securities have not been registered under the U.S.
Securities Act or any state securities laws by reason of specific

6

--------------------------------------------------------------------------------

    exemptions under the provisions thereof which depend in part upon the
investment intent of Purchaser and of the other representations made by
Purchaser in this Purchase Agreement. Purchaser understands that the Company is
relying upon the representations and agreements contained in this Purchase
Agreement (and any supplemental information) for the purpose of determining
whether this transaction meets the requirements for such exemptions.

(ii)
Purchaser understands that the Securities are “restricted securities” under
applicable federal securities laws and that the U.S. Securities Act and the
rules of the United States Securities and Exchange Commission (the “SEC” or the
“Commission”) provide in substance that Purchaser may dispose of the Offered
Securities only pursuant to an effective registration statement under the U.S.
Securities Act or an exemption therefrom, and Purchaser understands that the
Company has no obligation or intention to register any of the Offered
Securities, or to take action so as to permit sales pursuant to the U.S.
Securities Act (including Rule 144 thereunder). Accordingly, Purchaser
understands that under the Commission's rules, Purchaser may dispose of the
Offered Securities principally only in “private placements” which are exempt
from registration under the U.S. Securities Act, in which event the transferee
will acquire “restricted securities” subject to the same limitations as in the
hands of Purchaser. Consequently, Purchaser understands that Purchaser must bear
the economic risks of the investment in the Offered Securities for an indefinite
period of time.

(iii)
Purchaser agrees: (A) that Purchaser will not sell, assign, pledge, give,
transfer or otherwise dispose of the Offered Securities or any interest therein,
or make any offer or attempt to do any of the foregoing, except pursuant to a
registration of the Offered Securities under the U.S. Securities Act and all
applicable State Securities Laws, or in a transaction which is exempt from the
registration provisions of the U.S. Securities Act and all applicable State
Securities Laws; (B) that the certificates representing the Offered Securities
will bear a legend making reference to the foregoing restrictions; and (C) that
the Company and its affiliates shall not be required to give effect to any
purported transfer of such Offered Securities except upon compliance with the
foregoing restrictions.  Purchaser acknowledges that neither the Company nor any
other person offered to sell the Offered Securities to it by means of any form
of general solicitation or advertising, including but not limited to: (A) any
advertisement, article, notice or other communication published in any
newspaper, magazine or similar media or broadcast over television or radio or
(B) any seminar or meeting whose attendees were invited by any general
solicitation or general advertising.

(f)
No Hedging:  Neither the Purchaser nor any of its affiliates will, directly or
indirectly hold or maintain any short position in or engage in hedging
transactions with respect to the common stock of the Company or any other
securities of the Company, other than in accordance with the U.S. Securities
Act.

 
3. Representations and Warranties of the Company: AntriaBio hereby represents
and warrants to Purchaser that:
 
     a. Good Standing. The Company is duly formed and validly existing under the
laws of Delaware, with full power and authority to conduct its business as it is
currently being conducted and to
 
7

--------------------------------------------------------------------------------

 
own its assets; and has secured any other authorizations, approvals, permits and
orders required by law for the conduct by the Company of its business as it is
currently being conducted.
 
    b. Authorization. The Offered Securities have been duly authorized and, when
issued, delivered and paid for in the manner set forth in this Purchase
Agreement, will be validly issued, fully paid and non-assessable, and will
conform in all material respects to the description thereof set forth in the
Memorandum. The Common Stock issuable upon the issuance and exercise of the
Offered Securities has been duly reserved for issuance, and upon issuance in
accordance with the terms of the Company’s Certificate of Incorporation, will be
duly authorized, validly issued, fully paid and non-assessable, and free of
restrictions on transfer other than restrictions on transfer under any agreement
between the Company and the Investor, and applicable federal and state
securities laws.  This Agreement constitutes the valid and binding obligation of
the Company, enforceable in accordance with its terms, except that enforcement
of this Agreement and the terms of the Offered Securities may be limited by
bankruptcy, insolvency, moratorium or other similar laws relating to or
affecting the rights of creditors generally and subject to the fact that
equitable remedies are discretionary and may not be granted by a court of
competent jurisdiction.
c. Subsidiaries.  The Company does not currently own or control, directly or
indirectly, any interest in any other corporation, partnership, trust, joint
venture, limited liability company, association, or other business entity.  The
Company is not a participant in any joint venture, partnership or similar
arrangement other than its newly established subsidiary in Korea.
d. No Default. The execution, delivery and performance of this Agreement by the
Company and the consummation by the Company of the transactions contemplated
hereby do not and will not constitute a default under any of the terms,
conditions or provisions of the Certificate of Incorporation or Bylaws of the
Company, or any material contract, agreement or arrangement to which the Company
is a party or by which it is bound.
e. Compliance with Laws; Permits. The Company holds all material licenses,
approvals, certificates, permits and authorizations necessary for the lawful
conduct of its business and is in material compliance with all applicable laws,
rules, regulations and ordinances.  The Company has all franchises, permits,
licenses, and any similar authority necessary for the conduct of its business,
the lack of which could materially and adversely affect the business,
properties, prospects or financial condition of the Company.  The Company is not
in default in any material respect under any such franchise, permit, license or
other similar authority.
f. Litigation. There is no action, suit, proceeding at law or in equity,
arbitration or administrative or other proceeding by or before (or to the best
knowledge, information and belief of the Company any investigation by) any
governmental or other instrumentality or agency, pending, or, to the Company’s
knowledge, information and belief, threatened against or affecting the Company
or any of its properties, intellectual property and patents, or other rights
which could materially and adversely affect the right or ability of the Company
to carry on its business as now conducted, or which could materially and
adversely affect the condition, whether financial or otherwise, or properties or
intellectual property of the Company; and the Company does not know of any valid
basis for any such action, proceeding or investigation.
g. Intellectual Property. To the knowledge of the Company, the Company owns or
possesses or believes it can obtain on commercially reasonable terms sufficient
legal rights to all patents, trademarks, service marks, trade names, copyrights,
trade secrets, licenses (software or otherwise), information, processes and
similar proprietary rights (collectively “Intellectual Property”) necessary to
conduct the business of the Company as it is presently conducted or as presently
contemplated to be conducted (“Company Intellectual Property”) without any known
conflict with, or infringement of, the rights of others. To the Company’s
knowledge, no product or service marketed or
8

--------------------------------------------------------------------------------

sold (or proposed to be marketed or sold) by the Company violates or will
violate any license or infringes or will infringe any intellectual property
rights of any other party.  Except for agreements with its own employees,
consultants and customers and standard end-user license agreements and as
otherwise disclosed in the Company’s annual or quarterly filings with the SEC,
there are no outstanding options, licenses or agreements relating to the Company
Intellectual Property, and the Company is not bound by or a party to any
options, licenses or agreements with respect to the Intellectual Property of any
other person or entity.  The Company has not received any written communication
alleging that the Company has violated or, by conducting its business, would
violate any of the Intellectual Property of any other person or entity. To the
knowledge of the Company, it will not be necessary to use any inventions of any
of its employees or consultants (or persons it currently intends to hire) made
prior to their employment by the Company.  Each employee of the Company has
executed a customary confidential information and invention assignment
agreement. To the knowledge of the Company, no such employee or consultant is in
violation of such confidential information and invention assignment agreement.
h. Property.  The property and assets that the Company owns are free and clear
of all mortgages, deeds of trust, liens, loans and encumbrances, except for
statutory liens for the payment of current taxes that are not yet delinquent and
encumbrances and liens that arise in the ordinary course of business and do not
materially impair the Company’s ownership or use of such property or assets. 
With respect to the property and assets it leases, the Company is in material
compliance with such leases and holds a valid leasehold interest free of any
liens, claims or encumbrances other than those of the lessors of such property
or assets.  The Company does not own any real property.
i. Tax Returns and Payments.  There are no federal, state, county, local or
foreign taxes due and payable by the Company which have not been timely paid. 
There are no accrued and unpaid federal, state, county, local or foreign taxes
of the Company which are due, whether or not assessed or disputed.  There have
been no examinations or audits of any tax returns or reports by any applicable
federal, state, local or foreign governmental agency.  The Company has duly and
timely filed all federal, state, county, local and foreign tax returns required
to have been filed by it and there are in effect no waivers of applicable
statutes of limitations with respect to taxes for any year.
j. Governmental Consents and Filings.  Assuming the accuracy of the
representations made by the Investors in Section 2 of this Agreement, no
consent, approval, order or authorization of, or registration, qualification,
designation, declaration or filing with, any federal, state or local
governmental authority on the part of the Company is required in connection with
the consummation of the transactions contemplated by the Purchase Agreement,
except for (i) the filing of the Charter with the Secretary of State of the
State of Delaware and (ii) filings pursuant to Regulation D of the U.S.
Securities Act, and applicable state securities laws, which have been made or
will be made in a timely manner.
k. Real Property Holding Corporation.  The Company is not and has never been a
U.S. real property holding corporation as defined in the United States Internal
Revenue Code of 1986, as amended.
l. Labor and Employment Matters.  To the Company’s knowledge, no Key Employee
intends to terminate their employment with the Company, nor does the Company
have a present intention to terminate the employment of any of the foregoing. 
The Company has complied in all material respects with all applicable laws
related to labor or employment, including provisions thereof relating to wages,
hours, working conditions, benefits, retirement, social welfare, equal
opportunity and collective bargaining.  For the purposes hereof, “Key Employee”
means any executive-level employee (including division director and vice
president-level positions).
9
 

--------------------------------------------------------------------------------

m. No “Bad Actor” Disqualifications. the Company has exercised reasonable care,
in accordance with SEC rules and guidance, to determine whether any Covered
Person (as defined below) is subject to any Disqualification Event (as defined
in Rule 506(d)(1)(i) through (viii) under the U.S. Securities Act). To the
Company’s knowledge, no Covered Person is subject to a Disqualification Event,
except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3) under
the U.S. Securities Act. The Company has complied, to the extent applicable,
with any disclosure obligations under Rule 506(e) under the U.S. Securities Act
(See “Plan of Distribution” in the Memorandum). “Covered Persons” are those
persons specified in Rule 506(d)(1) under the U.S. Securities Act, including the
Company; any predecessor or affiliate of the Company; any director, executive
officer, other officer participating in the offering, general partner or
managing member of the Company; any beneficial owner of 20% or more of the
Company’s outstanding voting equity securities, calculated on the basis of
voting power; any promoter (as defined in Rule 405 under the U.S. Securities
Act) connected with the Company in any capacity at the time of the sale of the
Securities; and any person that has been or will be paid (directly or
indirectly) remuneration for solicitation of purchasers in connection with the
sale of the Series A Preferred Stock (a “Solicitor”), any general partner or
managing member of any Solicitor, and any director, executive officer or other
officer participating in the Offering of any Solicitor or general partner or
managing member of any Solicitor.
10

--------------------------------------------------------------------------------

4.   Registration Rights
a. Antria shall use reasonable commercial efforts to (i) prepare and file with
the SEC within thirty (30) calendar days after the Closing Date a registration
statement (on Form S-3, SB-1, SB-2, S-1, or other appropriate registration
statement form reasonably acceptable to Purchaser) under the U.S. Securities Act
(the “Registration Statement”), at the sole expense of Antria, in respect of
Purchaser, so as to permit a public offering and resale of the shares of common
stock issuable upon the issuance or exercise of the Offered Securities
(collectively, the “Registrable Securities”) in the United States under the U.S.
Securities Act by Purchaser as a selling stockholder and not as underwriter; and
(ii) use commercially reasonable efforts to cause a Registration Statement to be
declared effective by the SEC as soon as possible, but in any event not later
than the earlier of ninety (90) calendar days following the Closing Date (the
Registration Deadline”). Antria will notify Purchaser of the effectiveness of
the Registration Statement within three (3) trading days (days in which the
OTCQB is open for quotation).  The initial Registration Statement shall cover
the resale of 100% of the Registrable Securities, for an offering to be made on
a continuous basis pursuant to Rule 415 (as promulgated by the Commission
pursuant to the U.S. Securities Act, as such Rule may be amended from time to
time, or any similar rule or regulation hereafter adopted by the Commission
having substantially the same purpose and effect as such Rule); provided,
however, that if 100% of the Registrable Securities included hereunder cannot be
registered, the number of Registrable Securities on the initial Registration
Statement shall be reduced pro-rata among all Purchasers.
 
b. Antria will use reasonable commercial efforts to maintain the Registration
Statement or post-effective amendment filed under this Section 4 effective under
the U.S. Securities Act until the earlier of the date (i) all of the Registrable
Securities have been sold pursuant to such Registration Statement or (ii)
Purchaser  receives an opinion of counsel to Antria, which opinion and counsel
shall be reasonably acceptable to Purchaser, the Company and the transfer agent,
that the Registrable Securities may be sold under the provisions of Rule 144.

c. All fees, disbursements and out-of-pocket expenses and costs incurred by
Antria in connection with the preparation and filing of the Registration
Statement and in complying with applicable securities and “blue sky” laws
(including, without limitation, all attorneys’ fees of Antria, registration,
qualification, notification and filing fees, printing expenses, escrow fees,
blue sky fees and expenses and the expense of any special audits incident to or
required by any such registration) shall be borne by Antria.  Purchaser shall
bear the cost of underwriting and/or brokerage discounts, fees and commissions,
if any, applicable to the Registrable Securities being registered and the fees
and expenses of its counsel.  Antria shall qualify any of the Registrable
Securities for sale in such states as Purchaser reasonably designates.  However,
Antria shall not be required to qualify in any state which will require an
escrow or other restriction relating to Antria and/or the sellers, or which will
require Antria to qualify to do business in such state or require Antria to file
therein any general consent to service of process.  Antria at its expense will
supply Purchaser with copies of the applicable Registration Statement and the
prospectus included therein and other related documents in such quantities as
may be reasonably requested by Purchaser.
11

--------------------------------------------------------------------------------

d. Purchaser will cooperate with Antria in all respects in connection with this
Agreement, including timely supplying all information reasonably requested by
Antria (which shall include completing the Selling Shareholder Questionnaire
attached hereto as Exhibit A, and all information regarding Purchaser and
proposed manner of sale of the Registrable Securities required to be disclosed
in any Registration Statement) and executing and returning all documents
reasonably requested in connection with the registration and sale of the
Registrable Securities and entering into and performing its obligations under
any underwriting agreement, if the offering is an underwritten offering, in
usual and customary form, with the managing underwriter or underwriters of such
underwritten offering.  Any delay or delays caused by Purchaser, or by any other
purchaser of securities of Antria having registration rights similar to those
contained herein, by failure to cooperate as required hereunder shall not
constitute a breach or default of Antria under this Agreement. Purchaser
understands and agrees that the Company’s obligations under this Section 4 with
respect to the preparation and filing of the Registration Statement are subject
to Purchaser or any other purchaser of securities of Antria having registration
rights similar to those contained herein, timely providing the Company with the
Selling Shareholder Questionnaire and all information reasonably requested by
the Company to prepare and file the Registration Statement.

5. Market Stand-Off:  Purchaser further agrees, if so requested by the Company
or any representative of its underwriters, to enter into such underwriter’s
standard form of “lockup” or “market standoff” agreement in a form satisfactory
to the Company and such underwriter. The Company may impose stop-transfer
instructions with respect to securities subject to the foregoing restrictions
until the end of any such restriction period.  Notwithstanding the foregoing,
this Section shall only apply to any Purchaser who owns, at the time of such
underwritten public offering, 3%, or more, of the issued and outstanding shares
of common or preferred stock of the Company on a fully-diluted basis.

6. Legend: The certificates representing the Offered Securities sold pursuant to
this Purchase Agreement will be imprinted with a legend in substantially the
following form:

“THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR THE SECURITIES
LAWS OF ANY STATE OR OTHER JURISDICTION. THE SECURITIES MAY NOT BE OFFERED,
SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT (1) PURSUANT TO AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OR (2) PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT, IN EACH CASE IN ACCORDANCE WITH
ALL APPLICABLE STATE SECURITIES LAWS AND THE SECURITIES LAWS OF OTHER
JURISDICTIONS, AND IN THE CASE OF A TRANSACTION EXEMPT FROM REGISTRATION, UNLESS
THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO IT
THAT SUCH TRANSACTION DOES NOT REQUIRE REGISTRATION UNDER THE SECURITIES ACT AND
SUCH OTHER APPLICABLE LAWS.”
7. Governing Law:  This Purchase Agreement shall be binding upon the parties
hereto, their heirs, executors, successors, and legal representatives.  The laws
of the State of Delaware shall govern the rights of the parties as to this
Agreement.
8. Indemnification: Purchaser acknowledges that it understands the meaning and
legal consequences of the representations and warranties contained herein, and
it hereby agrees to indemnify and hold harmless Antria and any other person or
entity relying upon such information thereof from and against any and all loss,
damage or liability due to or arising out of a breach of any representation,
warranty, or acknowledgement of Purchaser contained in this Agreement.
12

--------------------------------------------------------------------------------

9. Non-assignability:  Except as otherwise expressly provided herein, this
Agreement may not be assigned by Purchaser.
10. Entire Agreement:  This Agreement, including any supplements, schedules, or
exhibits hereto, as each is amended and supplemented from time to time contains
the entire agreement among the parties with respect to the acquisition of the
Offered Securities and the other transactions contemplated hereby, and there are
no representations, covenants or other agreements except as stated,
incorporated, or referred to herein.
11. Amendment: This Agreement may be amended or modified only by a writing
signed by the party or parties to be charged with such amendment or
modification.
12. Binding On Successors: All of the terms, provisions and conditions of this
Agreement shall be binding upon and inure to the benefit of the parties hereto
and their respective heirs, successors, and legal representatives.
13. Titles: The titles of the sections of this Agreement are for convenience of
reference only and are not to be considered in construing this Agreement.
14. Severability:  The unenforceability or invalidity of any provision of this
Agreement shall not affect the enforceability or validity of the balance of this
Agreement.
15. Disclosure Required Under State Law: The offering and sale of the securities
is intended to be exempt from registration under the securities laws of certain
states. Purchasers who reside or purchase the Offered Securities may be required
to make additional disclosures by the securities laws of various states and
agrees to provide such additional disclosures as requested by Antria upon
written request.

16. Notices: All notes or other communications hereunder (except payment) shall
be in writing and shall be deemed to have been duly given if delivered
personally or sent by registered or certified mail postage prepaid, or by
Express Mail Service or similar courier, addressed as follows:

 
If to Purchaser:             At the address designated on the signature page of
this Agreement.

If to the Company:       AntriaBio, Inc.
1450 Infinite Drive
Louisville, Colorado 80027
Attention:  Nevan Elam, CEO

With Copy to:               Dorsey & Whitney LLP
1400 Wewatta Street, Suite 400
Denver, Colorado 80202
Attention:  Michael L. Weiner, Esq.

17. Time of the Essence:  Time shall be of the essence of this Agreement in all
respects.

18. Facsimile and Counterpart Purchase Agreements:  Antria shall be entitled to
rely on delivery of a facsimile or electronic copy of this Agreement executed by
the purchaser, and acceptance by Antria of such executed Agreement shall be
legally effective to create a valid and binding agreement between Purchaser and
Antria in accordance with the terms hereof. In addition, this Agreement may be
 
13

--------------------------------------------------------------------------------

 
executed in counterparts, each of which shall be deemed an original and all of
which shall constitute one and the same document.

19. Future Assurances:  Each of the parties hereto will from time to time
execute and deliver all such further documents and instruments and do all acts
and things as the other party may, either before or after a Closing, reasonably
require to effectively carry out or better evidence or perfect the full intent
and meaning of this Agreement.

[Signature page follows.]
 
14

--------------------------------------------------------------------------------

PURCHASER HEREBY DECLARES AND AFFIRMS THAT IT HAS READ THE WITHIN AND FOREGOING
PURCHASE AGREEMENT, IS FAMILIAR WITH THE CONTENTS THEREOF AND AGREES TO ABIDE BY
THE TERMS AND CONDITIONS THEREIN SET FORTH, AND KNOWS THE STATEMENTS THEREIN TO
BE TRUE AND CORRECT.

******

IN WITNESS WHEREOF, Purchaser executed this Agreement this      day of
____________, 201_.

PURCHASER:

By:*_________________________________________

Title:_________________________________________

Registration and Delivery Instructions:
 
 
 
_____________________________________________

_____________________________________________
(Address)
 
_____________________________________________

*
By the foregoing signature, I hereby certify to AntriaBio, Inc. that I am duly
empowered and authorized to provide the foregoing information.

This Purchase Agreement is hereby accepted by the Company this ____ day of
______________, 201__.

ANTRIABIO, INC.

By:___________________________  
Name:  Nevan Elam
Title:  Chief Executive Officer
 
15

--------------------------------------------------------------------------------

EXHIBIT A

SELLING SHAREHOLDER QUESTIONNAIRE

To:          AntriaBio, Inc.
 1450 Infinite Drive
 Louisville, Colorado 80027

Complete and Return with Your Subscription Agreement

Capitalized terms used herein but not otherwise defined shall have the meaning
set forth in that certain Subscription Agreement to which this Questionnaire is
attached.  This Questionnaire is being delivered to you in connection with a
registration statement to be filed with the United States Securities and
Exchange Commission.  Your securities will not be registered unless you complete
this Questionnaire and return it as instructed.
A. BACKGROUND INFORMATION
Name:___________________________________________________________________________________________________ 
Business
Address:_________________________________________________________________________________________
 (Number and Street)
 
________________________________________________________________________________________________________
(City) (State) (Zip Code)
Telephone
Number:_________________________________________________________________________________________
If a corporation, partnership, limited liability company, trust or other entity:
 Type of entity:
______________________________________________________________________________________ 
 State of formation:_____________________________ Date of
formation:__________________________________ 
Social Security or Taxpayer Identification
No.______________________________________________________________________ 
Email address of contact
person:________________________________________________________________________________ 

Number of Shares you are requesting to be registered in the Registration
Statement:
__________ Common Shares

Exhibit A

--------------------------------------------------------------------------------

BENEFICIAL OWNERSHIP INFORMATION: Please describe the beneficial ownership of
the shares and/or warrants owned by you or your organization.  If the
undersigned is a partnership, limited liability company or similar entity,
please identify the individual or individuals with ultimate voting and
dispositive power over such shares and/or warrants, typically the investment
manager or investment advisor with primary responsibility for this investment. 
This information is available from your compliance officer or general counsel. 
THE COMPANY WILL NOT BE ABLE TO REGISTER YOUR SECURITIES WITHOUT THIS IMPORTANT
INFORMATION.
Exception: This information need not be provided if the undersigned is a
publicly traded company.

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

Have you or your organization had any position, office or other material
relationship within the past three years with the Company or its affiliates?
[   ] Yes [   ] No
If yes, please indicate the nature of any such relationships below:

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

If you, any of your associates, or any member of your immediate family had or
will have any direct or indirect material interest in any transaction or series
of transactions to which the Company or any of its subsidiaries was a party
within the past three years, or in any currently proposed transactions or series
of transactions in which the company or any of its subsidiaries will be a party,
in which the amount involved exceeds $120,000, please specify (a) the names of
the parties to the transaction(s) and their relationship to you, (b) the nature
of the interest in the transaction, (c) the amount involved in the transaction,
and (d) the amount of the interest in the transaction.  If the answer is “none”,
please so state.

__________________________________________________________________________________________________
 
__________________________________________________________________________________________________
 __________________________________________________________________________________________________
__________________________________________________________________________________________________
 
Are you (i) an FINRA Member (see definition), (ii) a Controlling (see
definition) shareholder of an FINRA Member, (iii) a Person Associated with a
Member of the FINRA (see definition), or (iv) an Underwriter or a Related Person
(see definition) with
 
Exhibit A

--------------------------------------------------------------------------------

respect to the proposed offering; or (b) do you own any shares or other
securities of any FINRA Member not purchased in the open market; or (c) have you
made any outstanding subordinated loans to any FINRA Member? IN RESPONDING TO
THIS QUESTION, INDICATE WHETHER OR NOT YOU ARE A BROKER DEALER OR IF YOU ARE
AFFILIATED WITH A BROKER DEALER, AND IF SO, STATE THE NATURE OF YOUR
AFFILIATION.
[   ] Yes [   ] No
If “yes,” please describe below
 

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

 

You agreed to update the information in this Questionnaire if any of your
responses change.
Exhibit A

--------------------------------------------------------------------------------

IN WITNESS WHEREOF, the undersigned has executed this Questionnaire this ____
day of ________, 201__, and declares under oath that it is truthful and correct.

_______________________________________
Printed Name

By: ____________________________________ 
Its:_____________________________________

Return each completed and signed Questionnaire with your Subscription Agreement.
FINRA Member.  The term “FINRA member” means either any broker or dealer
admitted to membership in the Financial Industry Regulatory Authority, Inc.
(“FINRA”).  (FINRA Manual, By-laws Article I, Definitions)
Control.  The term “control” (including the terms “controlling,” “controlled by”
and “under common control with”) means the possession, direct or indirect, of
the power, either individually or with others, to direct or cause the direction
of the management and policies of a person, whether through the ownership of
voting securities, by contract, or otherwise.  (Rule 405 under the Securities
Act of 1933, as amended)
Person Associated with a member of the FINRA.  The term “person associated with
a member of the FINRA” means every sole proprietor, partner, officer, director,
branch manager or executive representative of any FINRA Member, or any natural
person occupying a similar status or performing similar functions, or any
natural person engaged in the investment banking or securities business who is
directly or indirectly controlling or controlled by a FINRA Member, whether or
not such person is registered or exempt from registration with the FINRA
pursuant to its bylaws.  (FINRA Manual, By-laws Article I, Definitions)
Underwriter or a Related Person.  The term “underwriter or a related person”
means, with respect to a proposed offering, underwriters, underwriters’ counsel,
financial consultants and advisors, finders, members of the selling or
distribution group, and any and all other persons associated with or related to
any of such persons.  (FINRA Interpretation)
Exhibit A

--------------------------------------------------------------------------------